Raytronics Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.56 M
as on 24-12-2024
- Revenue 20.47%
(FY 2021)
- Profit -5703.60%
(FY 2021)
- Ebitda -2482.77%
(FY 2021)
- Net Worth -531.73%
(FY 2021)
- Total Assets -0.74%
(FY 2021)
About Raytronics Medical Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.56 M.
Imran Shaikh and Vardhini Kulkarni serve as directors at the Company.
- CIN/LLPIN
U29190PN2016PTC165056
- Company No.
165056
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Raytronics Medical Systems Private Limited offer?
Raytronics Medical Systems Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, X Ray Machine, C Arm Machine, Patient Monitoring System, Cardiac & Multi Parameter Patient Monitor, CR Machine, AGFA CR Machine, Siemens X Ray Machine, Used Machinery & Tools, Refurbished Medical Equipment.
Who are the key members and board of directors at Raytronics Medical Systems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Imran Shaikh  | Director | 17-Jun-2016 | Current |
| Vardhini Kulkarni | Director | 17-Jun-2016 | Current |
Financial Performance of Raytronics Medical Systems.
Raytronics Medical Systems Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 20.47% increase. The company also saw a substantial fall in profitability, with a 5703.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 531.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raytronics Medical Systems?
In 2021, Raytronics Medical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Jan 2022 | ₹0.79 M | Open |
Others Creation Date: 23 Jun 2020 | ₹0.77 M | Open |
How Many Employees Work at Raytronics Medical Systems?
Unlock and access historical data on people associated with Raytronics Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raytronics Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raytronics Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
